Urinary Excretion Profiles of 5-Methoxy-N,N-diisopropyltryptamine and Its Relevant Metabolites in Humans
Tooru Kamata, Munehiro Katagi, Hiroe Kamata, Akihiro Miki, Noriaki Shima, Kei Zaitsu, Mayumi Nishikawa, Hitoshi Tsuchihashi
JOURNAL OF HEALTH SCIENCE January 1, 2007 DOI: 10.1248/jhs.53.585 via OpenAlex
Summary
AI-generated from the abstractIn urine from six users of the psychedelic tryptamine 5-MeO-DIPT, three metabolites—5-OH-DIPT, 6-OH-5-MeO-DIPT, and 5-MeO-NIPT—were identified. Using enzymatic hydrolysis with ascorbic acid to prevent degradation, conjugated forms (sulfates and glucuronides) of the hydroxylated metabolites were fully cleaved, greatly increasing their detection, especially for 6-OH-5-MeO-DIPT. After hydrolysis, concentrations of 5-OH-DIPT ranged from 0.01 to 47 μg/ml and 6-OH-5-MeO-DIPT up to 69 μg/ml, while the parent drug and 5-MeO-NIPT remained below 1.7 and 3.5 μg/ml, respectively. Metabolites were detectable longer than the parent compound: 5-OH-DIPT up to 80 hours, 6-OH-5-MeO-DIPT and 5-MeO-NIPT up to 60 hours, versus 35 hours for 5-MeO-DIPT.
Study at a glance
| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Sample size | 6 |
| Population | Human users of 5-MeO-DIPT |
| Keywords | Chromatography Hydrolysis Urine Biochemistry |
| Citations | 4 |
| Key finding | Hydrolyzed metabolites 5-OH-DIPT and 6-OH-5-MeO-DIPT were present at higher concentrations and detectable for longer periods than the parent drug 5-MeO-DIPT in urine from users. |
Abstract
5-Methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), a psychotomimetic tryptamine derivative, and its relevant metabolites have been determined in eleven urine specimens from six 5-MeO-DIPT users, and their excretion profiles have been investigated by gas chromatography/mass spectrometry (GC/MS) and liquid chromatography/mass spectrometry (LC/MS). Three metabolites, 5-hydroxy-N,N-diisopropyltryptamine (5-OH-DIPT), 6-hydroxy-5-methoxy-N,N-diisopropyltryptamine (6-OH-5-MeO-DIPT), and 5-methoxy-N-isopropyltryptamine (5-MeO-NIPT) were determined in the urine specimens. Urinary conjugated metabolites, both sulfates and glucuronides of 5-OH-DIPT and 6-OH-5-MeO-DIPT, were hydrolyzed completely by the use of Helix pomatia sulfatase/β-glucuronidase. Degradation of 6-OH-5-MeO-DIPT during incubation for hydrolysis was successfully prevented by the addition of ascorbic acid. The hydrolysis treatment increased the detection amounts of 5-OH-DIPT and 6-OH-5-MeO-DIPT in most of the specimens, and the increase in 6-OH-5-MeO-DIPT was more drastic than that in 5-OH-DIPT. The concentrations of 5-MeO-DIPT (<1.7 μg/ml) and 5-MeO-NIPT (<3.5 μg/ml) were lower than those of 5-OH-DIPT (0.01-47 μg/ml) and 6-OH-5-MeO-DIPT (<69 μg/ml) detected after hydrolysis (the totals of their free and conjugated forms). These metabolites were detectable over longer periods post intake than the parent drug; 35 hr for 5-MeO-DIPT, 80 hr for 5-OH-DIPT, and 60 hr for 6-OH-5-MeO-DIPT and 5-MeO-NIPT.